RCA has successfully conducted over 250 gastroenterology and hepatology trials
Research Centers of America’s investigators, including our Chief Medical Officer who is double boarded in Internal Medicine and Gastroenterology, have successfully conducted over 250 gastroenterology and hepatology trials. Our staff has extensive experience from First-in-Human (FIH), Phase I trials to the conduct of Phase III pivotal trials and subsequent regulatory approval.
Our areas of expertise include Phase I hepatic impaired and endoscopic safety, anesthesia, Irritable Bowel Syndrome (IBS), Gastroesophageal reflux disease (GERD), nonalcoholic steatohepatitis (NASH), Hepatitis, Crohn’s, H. Pylori, Colonoscopy Prep, and Ulcerative Colitis. RCA’s affiliation with a large practice and an onsite surgical center’s robust patient population has allowed us access to challenging, special populations, while frequently exceeding enrollment goals.
RCA’s Gastroenterology/Hepatology technologies and assessment abilities include:
- Endoscopy with Video Capabilities
- Liver Biopsies
- Gastric Acid Analysis